Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WI/Madison
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Madison, WI

Studies commonly pay $75 to $4,500 per completed study

520 clinical trials are currently recruiting participants within 30 miles of Madison. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

520studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Madison right now

Top 25 of 520 recruiting studies, sorted by proximity — each links to its official registry page

Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform

Any Solid Oral Medication N/A Interventional 200 participants sought
Lumicera — Madison, Wisconsin (0.8 mi) · Sponsor: Dosentrx Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT06344416)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
University of Wisconsin Carbone Cancer Center- University Hospital — Madison, Wisconsin (0.8 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial

Tibial Fractures, Pain Phase 3 Interventional 1,000 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi) · Sponsor: Major Extremity Trauma Research Consortium
See eligibility & contact on ClinicalTrials.gov (NCT07006675)

A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants

Healthy Volunteers Phase 1 Interventional 10 participants sought
Fortrea Clinical Research Unit Inc. — Madison, Wisconsin (0.8 mi) · Sponsor: Eisai Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07308236)

Temporal Interference for Thalamocortical Activity and Network Modulation

Healthy Participants Phase 1 Interventional 40 participants sought
University of Wisconsin - Madison — Madison, Wisconsin (0.8 mi) · Sponsor: University of Wisconsin, Madison
See eligibility & contact on ClinicalTrials.gov (NCT07219719)

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Relapsed Refractory Multiple Myeloma Phase 3 Interventional 508 participants sought
Research Site — Madison, Wisconsin (0.8 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07391657)

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Solid Tumor, Advanced Cancer Phase 1 Interventional 330 participants sought
UW Carbone Cancer Center — Madison, Wisconsin (0.8 mi) · Sponsor: I-Mab Biopharma US Limited
See eligibility & contact on ClinicalTrials.gov (NCT04900818)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
University of Wisconsin Carbone Cancer Center - University Hospital — Madison, Wisconsin (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NonSegmental Vitiligo Phase 3 Interventional 180 participants sought
University of Wisconsin School of Medicine — Madison, Wisconsin (0.8 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06548360)

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought
William S Middleton VA Medical Center — Madison, Wisconsin (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06672146)

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

Ovarian Cancer, Fallopian Tube Cancer Phase 2 Interventional 220 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06787612)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
William S Middleton VA Medical Center — Madison, Wisconsin (0.8 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate

Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostate Cancer) Phase 2 Interventional 126 participants sought
University of Wisconsin Carbone Cancer Center-Madison — Madison, Wisconsin (0.8 mi) · Sponsor: Prostate Cancer Clinical Trials Consortium
See eligibility & contact on ClinicalTrials.gov (NCT06844383)

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness Phase 3 Interventional 52 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi) · Sponsor: Vertex Pharmaceuticals Incorporated
See eligibility & contact on ClinicalTrials.gov (NCT04786262)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
William S Middleton VA Medical Center — Madison, Wisconsin (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

Relapsed/Refractory Multiple Myeloma Phase 1, Phase 2 Interventional 246 participants sought
University of Wisconsin Carbone Cancer Center — Madison, Wisconsin (0.8 mi) · Sponsor: BeOne Medicines
See eligibility & contact on ClinicalTrials.gov (NCT04973605)

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Breast Cancer, Early Breast Cancer Phase 3 Interventional 4,300 participants sought
Research Site — Madison, Wisconsin (0.8 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT05774951)

IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)

Non Small Cell Lung Cancer Phase 2 Interventional 70 participants sought
UW Carbone Cancer Center - Cancer Connect — Madison, Wisconsin (0.8 mi) · Sponsor: Innate Pharma
See eligibility & contact on ClinicalTrials.gov (NCT05742607)

Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study

Mitral Regurgitation, Tricuspid Regurgitation N/A Observational 550 participants sought
University of Wisconsin Hospital and Clinics — Madison, Wisconsin (0.8 mi) · Sponsor: Abbott Medical Devices
See eligibility & contact on ClinicalTrials.gov (NCT04761120)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center — Madison, Wisconsin (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)
Google-rated

Top-rated research centers in Madison

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

UW Health Wisconsin Institutes for Medical Research

★ 4.9
1111 Highland Ave, Madison, WI 53705
(608) 265-3270
"Always greeted promptly and respectfully. Appointment begins right on time. Ample privacy for changing."
— Robin Douthitt, 5★

Center for Health Disparities Research

UW Hospital and Clinics, 600 Highland Ave, MSC 3690, K4, Madison, WI 53792

Fortrea Clinical Trials MSN

★ 2.7
3402 Kinsman Blvd, Madison, WI 53704
(866) 429-3700
"I have participated in studies with Fortrea several times over the years and had built positive relationships with some staff members, which made my …"
— Merrisa M, 1★

UW Cardiovascular Research Center

Wisconsin Institute for Medical Research, 8503, 1111 Highland Ave, Madison, WI 53705

UW Center for Precision Medicine (CPM)

1111 Highland Ave Rm 2700, Madison, WI 53705
(608) 263-7866

Center For Health Systems Research and Analysis

★ 5.0
Warf Office Bldg, 610 Walnut St, Madison, WI 53726
(608) 263-5722

Center for Healthy Minds

★ 4.3
625 W Washington Ave, Madison, WI 53703
(608) 263-6321
"I really love their app. It's been a huge help."
— Abbey Dove, 5★

Covance Clinical Research Unit

★ 3.6
3402 Kinsman Blvd, Madison, WI 53704
(866) 429-3700
"I screened awhile ago It went well. I hear nothing but good about this place. I hope I have better luck next time."
— William, 5★

McArdle Laboratory for Cancer Research

★ 5.0
1111 Highland Ave, Madison, WI 53705
(608) 262-2177

Clinical trials in Madison: what's recruiting

The Madison area currently has 520 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Madison, the most active research areas are:

  • Cancer & Oncology13 studies
  • Brain & Mental Health1 studies
  • Diabetes & Metabolism1 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Madison, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Madison

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Madison participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Madison pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Madison?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Madison safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Madison, WI?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Madison typically complete one or two studies per year.

Paid clinical trials near Madison

Other metros within reach

Rockford, IL115 Milwaukee, WI693 Round Lake Beach, IL455 Appleton, WI152 Aurora, IL617 Naperville, IL2,362 Davenport, IA42 Joliet, IL521

More of WI

Milwaukee693 Appleton152 Green Bay149

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts